Boston Scientific Corporation (BSX) is scheduled to report fourth-quarter and full-year 2023 results on Jan 31, before the opening bell. In the last reported quarter, the company’s earnings per share of 50 cents exceeded the Zacks Consensus Estimate by 4.2%. BSX’s bottom line beat estimates in three of the trailing four quarters and missed on one occasion. The company has a trailing four-quarter earnings surprise of 4.34% on average. Factors at Play With U.S. hospitals reporting an increase in the number of ...